Skip to main content
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in via EAHP
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Current issue
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Current issue
Archive
Authors
About
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in via EAHP
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 19, Issue 6
EMA approved new drugs: ipilimumab (Yervoy) for the treatment of malignant melanoma
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
EMA new drug
EMA approved new drugs: ipilimumab (Yervoy) for the treatment of malignant melanoma
Online download statistics by month:
Online download statistics by month: November 2012 to March 2024
Abstract
Full
Pdf
Nov 2012
0
2
1
Dec 2012
0
0
3
Jan 2013
0
1
0
Mar 2013
0
0
2
Apr 2013
0
1
1
Jun 2013
3
1
0
Jul 2013
7
0
1
Aug 2013
7
0
0
Sep 2013
16
0
0
Oct 2013
7
0
0
Nov 2013
6
0
0
Dec 2013
7
0
0
Jan 2014
3
0
0
Feb 2014
7
0
0
Mar 2014
9
0
0
Apr 2014
11
0
0
May 2014
6
0
0
Jun 2014
12
0
1
Jul 2014
9
0
0
Aug 2014
8
0
0
Sep 2014
14
0
1
Oct 2014
13
0
0
Nov 2014
12
0
0
Dec 2014
7
1
0
Jan 2015
10
0
0
Feb 2015
11
0
0
Mar 2015
15
0
0
Apr 2015
12
0
1
May 2015
13
0
0
Jun 2015
18
0
1
Jul 2015
13
0
0
Aug 2015
6
0
0
Sep 2015
17
0
1
Oct 2015
6
0
0
Nov 2015
11
0
0
Dec 2015
22
0
0
Jan 2016
22
0
1
Feb 2016
9
0
0
Mar 2016
1
0
0
Apr 2016
7
0
0
May 2016
12
0
0
Jun 2016
9
0
0
Jul 2016
17
0
0
Aug 2016
12
0
0
Sep 2016
7
0
0
Oct 2016
23
0
0
Nov 2016
10
0
0
Dec 2016
13
0
3
Jan 2017
6
0
0
Feb 2017
7
0
0
Mar 2017
11
2
0
Apr 2017
11
0
0
May 2017
23
0
0
Jun 2017
12
0
0
Jul 2017
32
0
0
Aug 2017
33
0
1
Sep 2017
29
0
0
Oct 2017
37
0
0
Nov 2017
37
0
0
Dec 2017
29
1
0
Jan 2018
46
0
0
Feb 2018
45
0
3
Mar 2018
71
5
1
Apr 2018
45
2
0
May 2018
29
0
0
Jun 2018
28
0
0
Jul 2018
33
0
0
Aug 2018
43
0
0
Sep 2018
53
0
0
Oct 2018
25
0
2
Nov 2018
81
0
0
Dec 2018
37
1
0
Jan 2019
23
0
0
Feb 2019
56
0
0
Mar 2019
57
0
0
Apr 2019
79
1
0
May 2019
22
0
0
Jun 2019
13
1
0
Jul 2019
14
1
0
Aug 2019
10
0
0
Sep 2019
43
0
0
Oct 2019
48
0
2
Nov 2019
14
0
0
Dec 2019
16
0
0
Jan 2020
19
0
0
Feb 2020
18
0
0
Mar 2020
31
0
0
Apr 2020
52
1
0
May 2020
27
0
0
Jun 2020
33
0
0
Jul 2020
25
1
0
Aug 2020
22
0
0
Sep 2020
52
0
2
Oct 2020
66
0
1
Nov 2020
30
0
0
Dec 2020
32
0
0
Jan 2021
36
0
0
Feb 2021
26
0
0
Mar 2021
46
3
0
Apr 2021
25
1
0
May 2021
20
1
0
Jun 2021
2
1
0
Jul 2021
1
0
0
Aug 2021
4
0
0
Oct 2021
40
0
0
Nov 2021
36
0
0
Dec 2021
34
3
0
Jan 2022
32
0
0
Feb 2022
11
0
0
Mar 2022
40
0
0
Apr 2022
33
2
0
May 2022
44
0
0
Jun 2022
39
2
0
Jul 2022
16
0
0
Aug 2022
43
1
0
Sep 2022
28
0
0
Oct 2022
79
0
0
Nov 2022
30
2
0
Dec 2022
10
0
0
Jan 2023
11
0
0
Feb 2023
47
0
0
Mar 2023
16
0
0
Apr 2023
9
0
0
May 2023
14
0
0
Jun 2023
2
0
0
Jul 2023
20
0
0
Aug 2023
14
0
0
Sep 2023
4
0
0
Oct 2023
16
0
0
Nov 2023
24
0
0
Dec 2023
28
1
0
Jan 2024
29
0
0
Feb 2024
15
0
0
Mar 2024
13
0
0
Total
3002
39
29
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in via EAHP
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?